Companion Animal Pharmaceuticals Market - Forecasts to 2027
According to a new market research report published by Global Market Estimates, the Global Companion Animal Pharmaceuticals Market is projected to grow from USD 13.2 billion in 2022 to USD 19.5 billion by 2027 at a CAGR value of 7.8% from 2022 to 2027. The rapidly increasing number of pet ownership, accelerated commitment of owners to pay for optimal healthcare, expanded pet life expectancies, and the introduction of age-related illness targets such as rheumatoid arthritis, cancers, and obesity are all contributing to an explosive growth trend in the companion animal health sector during the forecast period.
Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Visually Impaired Assistive Apps Market Forecast to 2027" https://www.globalmarketestimates.com/market-report/companion-animal-pharmaceuticalsmarket-3773
By Indication (Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases, Behavioral Diseases, Other Indications), By Animal Type (Dogs, Cats, Horses, Other Companion Animals), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa), Company Market Share Analysis, and Competitor Analysis
Key Market Insights
As per indication, the dermatologic diseases segment is expected to grow the fastest in the market from 2022 to 2027. The dog segment is expected to be the largest segment in the market from 2022 to 2027 as per the animal type segmentation. As per distribution channel, the veterinary hospitals segment is expected to grow the fastest in the market from 2022 to 2027. North America (the United States, Canada, and Mexico) will have a dominant share in the Global Companion Animal Pharmaceuticals market from 2022 to 2027.
Zoetis Inc., Merck & Co., Inc., Boehringer Ingelheim GmbH, Elanco Animal Health Incorporated, Ceva Santé Animale, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals plc, Chanelle Pharma, Kyoritsu Seiyaku, among others are the key players in the companion animal pharmaceuticals market
Browse
the
Report
@ https://www.globalmarketestimates.com/market-report/companion-animal-
pharmaceuticals-market-3773
Indication Outlook (Revenue, USD Billion, 2022 - 2027)
Infectious Diseases
Dermatologic Diseases
Pain
Orthopedic Diseases
Behavioral Diseases
Other Indications
Animal Type Outlook (Revenue, USD Billion, 2022 - 2027)
Dogs
Cats
Horses
Other Companion Animals
Distribution Channel Outlook (Revenue, USD Billion, 2022 - 2027)
Veterinary Hospitals
Veterinary Clinics
Retail Pharmacies
Regional Outlook (Revenue, USD Billion, 2022-2027)
North America
The U.S. Canada Mexico
Europe
Germany UK France
Spain Italy
Rest of Europe
Asia Pacific
China India Japan South Korea Australia Rest of APAC
Central & South America
Brazil Argentina Rest of CSA
Middle East & Africa
Saudi Arabia UAE Rest of MEA
Contact: Yash Jain Email address: yash.jain@globalmarketestimates.com Phone Number: +16026667238
Website: Global Market Estimates Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php